ATRC | AtriCure, Inc.

Index- P/E- EPS (ttm)-0.82 Insider Own1.60% Shs Outstand46.11M Perf Week0.47%
Market Cap2.26B Forward P/E- EPS next Y-0.90 Insider Trans-1.36% Shs Float45.20M Perf Month-3.80%
Income-37.80M PEG- EPS next Q-0.29 Inst Own99.30% Short Float / Ratio3.76% / 5.57 Perf Quarter31.45%
Sales349.30M P/S6.47 EPS this Y-193.20% Inst Trans-1.48% Short Interest1.70M Perf Half Y9.52%
Book/sh9.86 P/B4.78 EPS next Y11.80% ROA-6.50% Target Price59.80 Perf Year12.02%
Cash/sh2.83 P/C16.65 EPS next 5Y20.00% ROE-8.30% 52W Range32.51 - 52.96 Perf YTD6.24%
Dividend- P/FCF- EPS past 5Y-5.00% ROI-8.10% 52W High-10.97% Beta1.36
Dividend %- Quick Ratio3.00 Sales past 5Y13.60% Gross Margin74.40% 52W Low45.03% ATR1.62
Employees1050 Current Ratio3.80 Sales Q/Q25.30% Oper. Margin-9.80% RSI (14)51.74 Volatility3.24% 3.38%
OptionableYes Debt/Eq0.14 EPS Q/Q57.90% Profit Margin-10.80% Rel Volume0.46 Prev Close47.86
ShortableYes LT Debt/Eq0.13 EarningsMay 02 AMC Payout- Avg Volume305.18K Price47.15
Recom1.70 SMA20-1.12% SMA504.68% SMA20010.11% Volume140,312 Change-1.48%
Date Action Analyst Rating Change Price Target Change
Aug-05-21Downgrade Oppenheimer Outperform → Perform
Dec-18-20Reiterated Needham Buy $53 → $63
Nov-06-20Reiterated Needham Buy $63 → $53
Apr-07-20Initiated Oppenheimer Outperform $45
Feb-06-20Initiated BTIG Research Buy $42
Jan-24-20Reiterated Needham Buy $39 → $48
Aug-13-19Downgrade Northland Capital Outperform → Market Perform $30
Apr-12-19Initiated JP Morgan Overweight $37
Oct-04-18Reiterated Needham Buy $36 → $39
Aug-02-18Reiterated Stifel Buy $32 → $34
May-25-23 04:02AM
May-04-23 06:21AM
May-03-23 10:50AM
May-02-23 05:25PM
04:01PM Loading…
Apr-19-23 08:00AM
Apr-17-23 10:42AM
Apr-11-23 08:00AM
Apr-03-23 08:00AM
Apr-01-23 09:41PM
Mar-27-23 08:29AM
Mar-18-23 09:14AM
Feb-25-23 02:14PM
Feb-21-23 05:15PM
04:14PM Loading…
Feb-17-23 08:00AM
Jan-31-23 08:00AM
Jan-24-23 08:00AM
Jan-09-23 08:00AM
Dec-31-22 08:07AM
Dec-20-22 08:00AM
Dec-08-22 10:30AM
Dec-04-22 07:20AM
Nov-08-22 08:00AM
Nov-01-22 05:55PM
Oct-26-22 10:01AM
Oct-25-22 10:01AM
08:00AM Loading…
Oct-11-22 08:00AM
Oct-09-22 08:53AM
Sep-06-22 08:00AM
Aug-16-22 08:00AM
Aug-02-22 05:15PM
Jul-28-22 09:44AM
Jul-20-22 08:00AM
Jul-12-22 08:00AM
Jul-06-22 07:09PM
Jun-18-22 09:31AM
Jun-07-22 08:00AM
Jun-01-22 01:16PM
May-05-22 12:45PM
May-04-22 03:39PM
May-03-22 05:15PM
May-02-22 08:30AM
Apr-28-22 05:45PM
Apr-12-22 08:00AM
Apr-11-22 08:00AM
Apr-09-22 09:43AM
Feb-23-22 07:23AM
Feb-16-22 10:00AM
Feb-15-22 05:15PM
Feb-10-22 05:35PM
Feb-08-22 03:00PM
Feb-03-22 08:55AM
Feb-01-22 08:00AM
Jan-27-22 05:25PM
Jan-25-22 08:00AM
Jan-20-22 09:38PM
Jan-14-22 11:33AM
Jan-10-22 07:00AM
Dec-20-21 08:00AM
Nov-12-21 08:00AM
Nov-08-21 10:07AM
Nov-04-21 02:01AM
Nov-03-21 06:05PM
Oct-27-21 03:04PM
Oct-26-21 08:00AM
Oct-25-21 03:37PM
Oct-05-21 08:00AM
Sep-20-21 09:23AM
Aug-31-21 08:00AM
Aug-12-21 02:11AM
Aug-04-21 11:31PM
Jul-30-21 08:00AM
Jul-28-21 03:03PM
Jul-07-21 08:00AM
Jun-15-21 07:00AM
May-14-21 01:09AM
Apr-30-21 06:57AM
Apr-29-21 07:00AM
Apr-28-21 11:30AM
Apr-27-21 05:25PM
Apr-08-21 08:00AM
Apr-06-21 08:00AM
Mar-02-21 04:01PM
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and the Coolrail device, which enable users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Guided Coagulation System, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure compatible with a range of anatomical shapes. In addition, the company sells Lumitip Dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments, which are used during surgical procedures for repair or replacement of certain heart valves. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dahlquist Karl S.Chief Legal OfficerJun 06Sale47.031,42266,87734,897Jun 07 08:43 AM
Yuen MaggieDirectorMay 26Sale47.044,313202,8844,682May 30 04:05 PM
Dahlquist Karl S.Chief Legal OfficerMay 01Sale44.834,417198,01436,319May 03 04:03 PM
Collar Mark ADirectorMar 13Option Exercise9.3010,00093,000100,871Mar 15 05:07 PM
WHITE ROBERT S.DirectorFeb 27Option Exercise8.4820,000169,60075,799Mar 01 04:52 PM
Doraiswamy VinayakChief Scientific OfficerSep 15Sale45.994,983229,16819,406Sep 19 04:49 PM
WHITE ROBERT S.DirectorAug 31Option Exercise8.4815,000127,20055,799Sep 02 04:03 PM